Rice Hall James & Associates LLC Trims Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Rice Hall James & Associates LLC trimmed its position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 1.0% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 545,128 shares of the company's stock after selling 5,684 shares during the period. Prestige Consumer Healthcare comprises approximately 2.8% of Rice Hall James & Associates LLC's holdings, making the stock its 5th largest holding. Rice Hall James & Associates LLC owned about 1.10% of Prestige Consumer Healthcare worth $46,865,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Diversify Wealth Management LLC lifted its stake in shares of Prestige Consumer Healthcare by 24.3% in the 1st quarter. Diversify Wealth Management LLC now owns 12,929 shares of the company's stock valued at $1,059,000 after purchasing an additional 2,530 shares during the period. Xponance Inc. raised its stake in Prestige Consumer Healthcare by 5.5% during the 1st quarter. Xponance Inc. now owns 3,766 shares of the company's stock worth $324,000 after buying an additional 196 shares during the period. Cerity Partners LLC raised its stake in Prestige Consumer Healthcare by 3.7% during the 1st quarter. Cerity Partners LLC now owns 3,666 shares of the company's stock worth $315,000 after buying an additional 132 shares during the period. Bridges Investment Management Inc. raised its stake in Prestige Consumer Healthcare by 38.4% during the 1st quarter. Bridges Investment Management Inc. now owns 3,774 shares of the company's stock worth $324,000 after buying an additional 1,048 shares during the period. Finally, EULAV Asset Management acquired a new stake in shares of Prestige Consumer Healthcare in the 1st quarter valued at about $1,668,000. 99.95% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Wall Street Zen raised Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Royal Bank Of Canada upgraded Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, Prestige Consumer Healthcare has a consensus rating of "Moderate Buy" and a consensus target price of $93.33.

Prestige Consumer Healthcare Price Performance

PBH traded up $0.03 during trading on Thursday, hitting $75.20. 565,155 shares of the stock traded hands, compared to its average volume of 315,394. Prestige Consumer Healthcare Inc. has a twelve month low of $64.94 and a twelve month high of $90.04. The company has a market cap of $3.72 billion, a price-to-earnings ratio of 17.53, a PEG ratio of 2.25 and a beta of 0.43. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.20 and a quick ratio of 2.82. The business has a 50 day moving average price of $83.16 and a 200 day moving average price of $82.28.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, topping analysts' consensus estimates of $1.30 by $0.02. The firm had revenue of $296.52 million for the quarter, compared to analysts' expectations of $289.36 million. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. The company's revenue was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.02 earnings per share. Equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.